The psychology of clinical decision making - Implications for medication use

New England Journal of Medicine

Volumn 378, Issue 8, 2018, Pages 689-691

  Avorn, Jerry ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL DECISION MAKING; CLINICAL PRACTICE; DEFENSE MECHANISM; DOCTOR PATIENT RELATION; DRUG CHOICE; DRUG MARKETING; DRUG USE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH CARE UTILIZATION; HEALTH ECONOMICS; HUMAN; MEDICAL PRACTICE; PATIENT CARE; PATIENT PREFERENCE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOLOGY; REVIEW; PHYSICIAN;

CLINICAL DECISION-MAKING; DRUG PRESCRIPTIONS; HUMANS; PHYSICIANS;

EID: 85042595529     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1714987     Document Type: Review

References (5)

1. Kahneman D. Thinking, fast and slow. New York: Farrar, Straus, and Giroux, 2011.
2. Avorn J. Academic detailing: "marketing" the best evidence to clinicians. JAMA 2017;317:3 61-2.
3. Thaler RH, Sunstein CR. Nudge: improving decisions about health, wealth, and happiness. New Haven, CT: Yale University Press, 2008.
4. Choudhry NK, Avorn J, Glynn RJ, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med 2011;365:2088-97.
5. Cohen IG, Lynch HF, Robertson CT, eds. Nudging health: health law and behavioral economics. Baltimore: Johns Hopkins University Press, 2016.